Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX; Department of Cardiovascular Medicine, Ain shams university, Cairo, Egypt.
Division of Cardiovascular Medicine, University of Florida, Gainesville, FL.
Am J Cardiol. 2019 Jan 1;123(1):25-32. doi: 10.1016/j.amjcard.2018.09.030. Epub 2018 Sep 27.
Several randomized trials have demonstrated the benefits of an invasive strategy for older patients with acute coronary syndromes (ACS); however, there are limited real-world data of the temporal trends in the use of percutaneous coronary intervention (PCI) in this population. This was a retrospective observational analysis. We queried the National Inpatient Sample database from 1998 to 2013 for patients aged ≥70 years who had non-ST-elevation acute coronary syndrome (NSTE-ACS) or ST-elevation myocardial infarction (STEMI). We reported the temporal trends of PCI and in-hospital mortality. A total of 6,720,281 hospitalizations with ACS were identified in advanced age patients, 18.3% of whom also underwent PCI. There was an upward trend in the rate of PCI in older adults ≥70 years with any ACS from 9.4% in 1998 to 28.3% in 2013 (p <0.001), as well as in cases of PCI for NSTE-ACS (7.3% in 1998 vs 24.9% in 2013, p <0.001) and PCI for STEMI (11% in 1998 vs 35.7% in 2013, p = 0.002). This upward trend was consistent in all age categories (70 to 79), (80 to 89) and ≥90 years. Despite an increase in the prevalence of comorbidities for ACS hospitalizations aged ≥70 years who received PCI, the in-hospital mortality rate showed a downward trend (p <0.001). Multivariate analysis adjusting for various comorbidities showed that PCI was associated with lower in-hospital mortality and length of hospital stay among elderly with NSTE-ACS and STEMI. In conclusion, in this 16-year analysis there was an increase in the rate of PCI procedures among older adults with ACS. PCI was independently associated with lower mortality in elderly patients with ACS.
几项随机试验已经证明了对急性冠状动脉综合征(ACS)老年患者采用有创策略的益处;然而,关于该人群中经皮冠状动脉介入治疗(PCI)的实际应用的时间趋势,仅有有限的真实世界数据。这是一项回顾性观察性分析。我们从 1998 年至 2013 年,在国家住院患者样本数据库中查询了年龄≥70 岁的非 ST 段抬高型急性冠状动脉综合征(NSTE-ACS)或 ST 段抬高型心肌梗死(STEMI)患者。我们报告了 PCI 和院内死亡率的时间趋势。在年龄较大的 ACS 患者中,共确定了 6720281 例住院治疗,其中 18.3%的患者接受了 PCI。在≥70 岁的老年人中,任何 ACS 患者接受 PCI 的比例从 1998 年的 9.4%上升至 2013 年的 28.3%(p<0.001),对于 NSTE-ACS 的 PCI 治疗(1998 年为 7.3%,2013 年为 24.9%,p<0.001)和 STEMI 的 PCI 治疗(1998 年为 11%,2013 年为 35.7%,p=0.002)也呈上升趋势。这种上升趋势在所有年龄组(70 至 79 岁)、(80 至 89 岁)和≥90 岁均一致。尽管≥70 岁接受 PCI 的 ACS 住院患者的合并症患病率有所增加,但院内死亡率呈下降趋势(p<0.001)。调整各种合并症后的多变量分析显示,对于 NSTE-ACS 和 STEMI 的老年患者,PCI 与较低的院内死亡率和住院时间相关。总之,在这项 16 年的分析中,ACS 老年患者的 PCI 率有所增加。PCI 与 ACS 老年患者死亡率降低独立相关。